Skip to main content
Premium Trial:

Request an Annual Quote

Patia Biopharma, Precision Diabetes to Collaborate on Diabetes Biomarker Development

NEW YORK — Patia Biopharma has partnered with Precision Diabetes to develop and commercialize new biomarkers for diabetes, the companies said on Wednesday.

Specific terms of the deal were not disclosed.

The companies are currently working together to commercialize each other's existing products and said they recently signed an agreement under which Raleigh, North Carolina-based Precision Diabetes is selling two of Patia's genetic tests — Diabetespredict for determining an individual's risk of developing type 2 diabetes and GDMpredict for evaluating gestational diabetes risk — in the US and Mexico.

Under a separate agreement, San Sebastian, Spain-based Patia is distributing Precision Diabetes' GlycoMark, a US Food and Drug Administration-cleared blood test for monitoring blood glucose variability in diabetics, in Europe and Mexico.

"In partnering with Patia … we are positioning the companies to be the leaders in precision diabetes diagnostics by bringing together both our unique diabetes test product portfolios and platforms which include commercialized tests and tests in development," Precision Diabetes CEO Eric Button said in a statement.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.